Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Местные гемостатические средства в хирургической онкогепатологии
Местные гемостатические средства в хирургической онкогепатологии
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Вишневский В.А. и др. Современные принципы техники оперативных вмешательств на печени. Анналы хир. гепатол. 1996; 1: 15–23.
2. Скипенко О.Г. и др. Проблемы гемостаза и герметизма при резекциях печени с использованием фибрин-коллагеновой субстанции. Хирургия. 2003; 9: 18–23.
3. Скипенко О.Г. и др. Резекция печени: ближайшие результаты 132 операций. Анналы хир. гепатол. 2006; 11 (4): 28–37.
4. Федоров В.Д. и др. Основные осложнения обширных резекций печени и пути их предупреждения. Бюл. сиб. мед. 2007; 3: 16–21.
5. Adam R et al. Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases. Analysis of 1452 Patients and Development of a Prognostic Model. Ann Surg 2006; 244 (4): 524–35.
6. Alkozai EM et al. Bleeding in liver surgery: prevention and treatment. Clin Liver Dis 2009; 13: 145–54.
7. Asahara T et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 1999; 23: 676–80.
8. Berrevoet F et al. Use of topical hemostatic agents during liver resection. Dig Surg 2007; 24: 288–93.
9. Birth M et al. Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study. Pat Saf Surg 2009; 3: 13.
10. Boonstra EA et al. Topical haemostatic agents in liver surgery: do we need them? HPB 2009; 11: 306–10.
11. Carbon RT et al. Tissue management with fleece-bound sealing: materials, material science and clinical implementation. 6th World Congress of Trauma, Shock, Inflammation and Sepsis, 2–6 March 2004.
12. Chapman WC et al. Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma. Results of a randomized controlled trial. Arch Surg 2001; 1200–4.
13. Capussotti L et al. Bile leakage and liver resection. Where is the risk? Arch Surg 2006; 141: 690–4.
14. Dickneite G et al. A comparison of fibrin sealants in relation to their in vitro and in vivo properties. Thromb Res 2003; 112: 73–82.
15. Erdogan D et al. Prevention of biliary leakage after partial liver resection using topical hemostatic agents. Dig Surg 2007; 24: 294–9.
16. Erdogan D et al. Adhesive strength of fibrinogen-coated collagen patch or liquid fibrin sealant in an experimental liver resection model in pigs. Eur Surg Res 2008; 41: 298–302.
17. Figueras J et al. Application of fibrin glue sealant after hepatectomy does not seem justified. Results of randomized study in 300 patients. Ann Surg 2007; 245: 536–42.
18. Frilling A et al. Effectiveness of new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomized prospective trial. Langenbecks Arch Surg 2005; 390: 114–20.
19. Fong Y et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. 1001 consecutive cases. Ann Surg 1999; 230 (3): 309–21.
20. Jarnagin WR et al. Improvement in perioperative outcome after hepatic resection. Analysis of 1803 consecutive cases over the past decade. Ann Surg 2002; 4: 397–407.
21. Jaeck D et al. Longterm survival following resection of colorectal hepatic metastases: Association Francaise de Chirurgie. Br J Surg 1997; 84: 977–80.
22. Kooby D et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237: 860–70.
23. Kraus WT et al. Scientific evidence for application of topical hemostats, tissue glues and sealants in hepatobiliary surgery. Am Col Surg 2005; 200 (3): 418–27.
24. Lam CM, Lo CM, Liu CL, Fan S. Biliary Complications during Liver Resection. W J Surg 2001; 25 (10): 1273–6.
25. Martin NE et al. Fibrin sealant for retinoblastoma: where are we? J Ocul Pharmacol Ther 2008; 24 (5): 433–8.
26. Meijer C et al. Coagulopathy following major liver resection: the effect of BPI and role of decreased synthesis of regulating proteins by the liver. Shock 2001; 15: 261–71.
27. Mullen JT et al. Hepatic insufficiency and mortality in 1059 noncirrhotic patient undergoing major hepatectomy. J Am Coll Surg. 2007; 204 (5): 854–62.
28. Nagano Y et al. Risk factors and management of bile leakage after hepatic resection. World J Surg 2003; 27: 695–8.
29. Nagino М et al. Complications of Hepatectomy for Hilar Cholangiocarcinoma. W J Surg 2001; 25 (10): 1277–83.
30. Nakajima Y et al. Control of intraoperative bleeding during liver resection. Analysis of a questionaire sent to 231 Japanese hospitals. Surg Today 2002; 32: 48–52.
31. Noun R et al. Fibrin glue effectiveness and tolerance after elective liver resection: a randomized trial. Hepatogastroenterology 1996; 43: 221–4.
32. Poon RT et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases. Analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240 (4): 698–708.
33. Schindl MJ et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289–96.
34. Schuman R et al. Altered hematologic profiles following donor right hepatectomy and implications for perioperative analgesic management. Liver Transpl 2004; 10 (3): 363–8.
35. Scwartz M et al. Comparison of new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004; 139: 1148–54.
36. Sierra DH. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J Biomater Appl 1993; 7: 309–52.
37. Simmonds PC et al. Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 2006; 94: 982–99.
38. Thompson HH et al. Major hepatic resection. A 25-year experience. Ann Surg 1983; 197 (4): 375–88.
39. Tredwell S et al. Use of fibrin sealants for localized, controlled release of cefasolin. Can J Surg 2006; 49 (5): 347–52.
2. Скипенко О.Г. и др. Проблемы гемостаза и герметизма при резекциях печени с использованием фибрин-коллагеновой субстанции. Хирургия. 2003; 9: 18–23.
3. Скипенко О.Г. и др. Резекция печени: ближайшие результаты 132 операций. Анналы хир. гепатол. 2006; 11 (4): 28–37.
4. Федоров В.Д. и др. Основные осложнения обширных резекций печени и пути их предупреждения. Бюл. сиб. мед. 2007; 3: 16–21.
5. Adam R et al. Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases. Analysis of 1452 Patients and Development of a Prognostic Model. Ann Surg 2006; 244 (4): 524–35.
6. Alkozai EM et al. Bleeding in liver surgery: prevention and treatment. Clin Liver Dis 2009; 13: 145–54.
7. Asahara T et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 1999; 23: 676–80.
8. Berrevoet F et al. Use of topical hemostatic agents during liver resection. Dig Surg 2007; 24: 288–93.
9. Birth M et al. Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study. Pat Saf Surg 2009; 3: 13.
10. Boonstra EA et al. Topical haemostatic agents in liver surgery: do we need them? HPB 2009; 11: 306–10.
11. Carbon RT et al. Tissue management with fleece-bound sealing: materials, material science and clinical implementation. 6th World Congress of Trauma, Shock, Inflammation and Sepsis, 2–6 March 2004.
12. Chapman WC et al. Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma. Results of a randomized controlled trial. Arch Surg 2001; 1200–4.
13. Capussotti L et al. Bile leakage and liver resection. Where is the risk? Arch Surg 2006; 141: 690–4.
14. Dickneite G et al. A comparison of fibrin sealants in relation to their in vitro and in vivo properties. Thromb Res 2003; 112: 73–82.
15. Erdogan D et al. Prevention of biliary leakage after partial liver resection using topical hemostatic agents. Dig Surg 2007; 24: 294–9.
16. Erdogan D et al. Adhesive strength of fibrinogen-coated collagen patch or liquid fibrin sealant in an experimental liver resection model in pigs. Eur Surg Res 2008; 41: 298–302.
17. Figueras J et al. Application of fibrin glue sealant after hepatectomy does not seem justified. Results of randomized study in 300 patients. Ann Surg 2007; 245: 536–42.
18. Frilling A et al. Effectiveness of new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomized prospective trial. Langenbecks Arch Surg 2005; 390: 114–20.
19. Fong Y et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. 1001 consecutive cases. Ann Surg 1999; 230 (3): 309–21.
20. Jarnagin WR et al. Improvement in perioperative outcome after hepatic resection. Analysis of 1803 consecutive cases over the past decade. Ann Surg 2002; 4: 397–407.
21. Jaeck D et al. Longterm survival following resection of colorectal hepatic metastases: Association Francaise de Chirurgie. Br J Surg 1997; 84: 977–80.
22. Kooby D et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237: 860–70.
23. Kraus WT et al. Scientific evidence for application of topical hemostats, tissue glues and sealants in hepatobiliary surgery. Am Col Surg 2005; 200 (3): 418–27.
24. Lam CM, Lo CM, Liu CL, Fan S. Biliary Complications during Liver Resection. W J Surg 2001; 25 (10): 1273–6.
25. Martin NE et al. Fibrin sealant for retinoblastoma: where are we? J Ocul Pharmacol Ther 2008; 24 (5): 433–8.
26. Meijer C et al. Coagulopathy following major liver resection: the effect of BPI and role of decreased synthesis of regulating proteins by the liver. Shock 2001; 15: 261–71.
27. Mullen JT et al. Hepatic insufficiency and mortality in 1059 noncirrhotic patient undergoing major hepatectomy. J Am Coll Surg. 2007; 204 (5): 854–62.
28. Nagano Y et al. Risk factors and management of bile leakage after hepatic resection. World J Surg 2003; 27: 695–8.
29. Nagino М et al. Complications of Hepatectomy for Hilar Cholangiocarcinoma. W J Surg 2001; 25 (10): 1277–83.
30. Nakajima Y et al. Control of intraoperative bleeding during liver resection. Analysis of a questionaire sent to 231 Japanese hospitals. Surg Today 2002; 32: 48–52.
31. Noun R et al. Fibrin glue effectiveness and tolerance after elective liver resection: a randomized trial. Hepatogastroenterology 1996; 43: 221–4.
32. Poon RT et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases. Analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240 (4): 698–708.
33. Schindl MJ et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289–96.
34. Schuman R et al. Altered hematologic profiles following donor right hepatectomy and implications for perioperative analgesic management. Liver Transpl 2004; 10 (3): 363–8.
35. Scwartz M et al. Comparison of new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004; 139: 1148–54.
36. Sierra DH. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J Biomater Appl 1993; 7: 309–52.
37. Simmonds PC et al. Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 2006; 94: 982–99.
38. Thompson HH et al. Major hepatic resection. A 25-year experience. Ann Surg 1983; 197 (4): 375–88.
39. Tredwell S et al. Use of fibrin sealants for localized, controlled release of cefasolin. Can J Surg 2006; 49 (5): 347–52.
Авторы
Н.Н.Багмет, Н.К.Чардаров, О.Г.Скипенко
Учреждение Российской академии медицинских наук
Российский научный центр хирургии им. акад. Б.В.Петровского РАМН, Москва
Учреждение Российской академии медицинских наук
Российский научный центр хирургии им. акад. Б.В.Петровского РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.